Prolapse
Prolapse
ProlapLase™
ProlapLase™ is a non-invasive Er:YAG laser therapy for treating pelvic organ prolapse (POP).
What is a vaginal (pelvic organ) prolapse?
Your pelvic organs include your bladder, uterus (womb) and rectum (back passage). These organs are held in place by tissues called ‘fascia’ and ‘ligaments’. These tissues help to join your pelvic organs to the bony side walls of the pelvis and hold them inside your pelvis.
Your pelvic floor muscles also hold up your pelvic organs from below. If the fascia or ligaments are torn or stretched for any reason, and if your pelvic floor muscles are weak, your pelvic organs might not be held in their right place, and they may bulge or sag down into the vagina. This is known as a pelvic organ prolapse (POP).
How does ProlapLase™ work?
The ProlapLase™ treatment is based on precisely controlled laser-induced photothermal effects of Fotona’s 2940 nm Er:YAG laser in mucosa tissue, stimulating collagen remodelling and the synthesis of new collagen fibres.
The result of collagen neogenesis and remodelling is shrinkage and tightening of the vaginal canal without removal of any tissue and, subsequently, improvement of prolapse. Patients may require between 2-4 treatments depending on the degree of severity of the prolapse.
* Individual Results May Vary. Consultation Is Required To Assess Client Requirements.
What are the unique advantages of ProlapLase™?
- ProlapLase™ is a minimally invasive, incision-less and virtually painless procedure. No cutting, bleeding or sutures, therefore recovery is exceptionally quick.
- ProlapLase™ requires no anesthesia, antibiotics or pain relief.
- ProlapLase™ is a safe, quick, walk-in/walk-out procedure with little to no downtime.
Results from Clinical Studies confirm that ProlapLase™ is an effective, safe and comfortable treatment for symptom relief in patients with mild or moderate cystocele, uterine or rectocele prolapse.
Scientific & Clinical Research:
Clinical Results:
Scientific results from clinical studies show excellent improvement for mild stress urinary incontinence. – Almost 70% of patients are dry after 120 days after IncontiLase treatment, 94% of patients reported improvement, and 68% of all patients claimed to be free of SUI symptoms.
Scientific & Clinical Research:
Novel Minimally Invasive VSP Er:YAG Laser Treatments in Gynecology – Read Full Text
Vizintin Z, Rivera M, Fistonić I, Saraçoglu F, Guimares P, Gaviria J, Garcia V, Lukac M, Perhavec T, Marini L.
Journal of the Laser and Health Academy, Vol. 2012, No. 1, P. 46-58.
Minimally Invasive Laser Procedure for Early Stages of Stress Urinary Incontinence (SUI) – Read Full Text
Fistonić I, Findri-Guštek Š, Fistonić N. Journal of the Laser and Health Academy, Vol. 2012, No. 1, P. 67-74.
Additional Resources:
Visit the Laser and Health Academy* website for further information.
* Individual results may vary. Consultation is required to assess client requirements.
